Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.46-15.17-80.40385.973,765.48

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is 17.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.46
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 17.46
Positive
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹209.0 Cr 2.3% 9.8% -43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,209.0 Cr 1% -6.4% -0.7% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 3.5% 3.4% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,746.0 Cr 0.2% -1.8% 33.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,851.0 Cr -0.2% -3.4% 11.4% Stock Analytics
CIPLA ₹99,268.4 Cr 1.5% -5.4% -15.4% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

2.3%

9.8%

-43.9%

SENSEX

1.3%

5.3%

6.3%


You may also like the below Video Courses